A Convenient Injection Option:
Offered with Professional Care at Home
Convenience and Quality Care
When you're getting Sandostatin® LAR Depot (octreotide acetate for injectable suspension) therapy for the severe diarrhea and flushing associated with carcinoid syndrome, you know how important it is to keep to your schedule and get your injections exactly as prescribed. That's why the Sandostatin® Nurse Home Injection Program (NHIP) was developed—to help make your life a little easier.
If your doctor recommends you as an appropriate patient to participate in the program and you're eligible, you'll be able to receive your injections at home, administered by a specially trained registered nurse. To take advantage of this convenient way to receive your injections:
- Print the enrollment form and bring it to your doctor
- Find out from your doctor if you're a candidate for home injections and check if you're eligible
Advantages of the Sandostatin® Nurse Home Injection Program
- Convenient professional care. When you're dealing with severe diarrhea and flushing associated with carcinoid syndrome, the program offers a convenient administration option, removing the stress of driving to the doctor's office and time spent in the waiting room
- Injections planned around your schedule. You can make the most of your time by scheduling injections when it suits you because nurses are available outside traditional office hours, including weekends and evenings or even when you are traveling out of town
- A professional source of care. Your registered nurse will have the time to answer your treatment-related questions and let your doctor know how you are doing. You'll be receiving professional care in the comfort of your own home
- Medicine you can trust. Sandostatin® offers you:
- Confidence and reliability of over 5 million doses of Sandostatin® LAR Depot administered worldwide*
- More than 20 years of unparalleled evidence, established through†
- Over 800,000 patient-years of experience†
- Over 6000 published articles†
- Over 600 clinical trials†‡
*For all approved indications.
†Combined use of immediate release Sandostatin® Injection and Sandostatin® LAR Depot for all indications.
‡Includes both ongoing and completed trials for all approved indications.
How the Sandostatin® NHIP Works
Just Five Simple Steps to Receive Your Injections At Home
1. Your doctor recommends you for the program and submits your enrollment form
2. BioScrip®, the administrator of the program, verifies your eligibility
3. BioScrip® calls you to schedule your next injection at your convenience
4. A specially trained treatment nurse is assigned to you
5. Your treatment nurse visits your home and:
- Assesses your condition and notes any change in your status
- Gives the injection
- Makes the next appointment, following up with a reminder
- Sends a report to your doctor
Important Things to Know About the NHIP
- The NHIP does not replace your doctor's care; you should still go to your regular doctor for check ups.The NHIP simply provides you with the convenience of receiving your injections at home on a flexible schedule
- If you are new to Sandostatin® LAR Depot, your first dose must be received in your doctor's office
- Depending on your insurance, your co-pay might change
Finding Out if You're Eligible for the Program
The Sandostatin® NHIP is an additional benefit for all eligible patients with the severe diarrhea and flushing associated with carcinoid syndrome for whom Sandostatin® LAR Depot has been prescribed.
- Residents of all states except Massachusetts, Michigan, Minnesota, and Rhode Island can participate
- The NHIP is available to eligible patients covered by most commercial plans (HMO, PPO, etc)
- Patients with government-provided medical insurance (eg, Medicare Part B and D, or Medicaid) are not eligible at this time
To Find Out if You're Eligible for the NHIP:
- Print the enrollment form and take it to your doctor
- Call 1-888-LAR-4759 (1-888-527-4759) and speak with a representative at BioScrip®, the program administrator
Get Instant Answers to Your Questions
Click on the questions below for answers to Frequently Asked Questions (FAQs) about the Sandostatin® NHIP.
- Am I eligible for this program based on my medical and pharmaceutical insurance coverage?
- According to my disease state, am I a candidate for this program?
- What are the main benefits of the Sandostatin® LAR Depot NHIP?
- How flexible is the scheduling?
- How is my nurse selected?
- How does the Sandostatin® LAR Depot get to my home?
- Will I still see my doctor regularly?
- Does this involve a lot of paperwork on my part?
To print a complete list of questions and answers, click here.
INDICATIONS AND USAGE
Sandostatin® LAR Depot (octreotide acetate for injectable suspension) is a prescription medicine indicated for patients in whom initial treatment with immediate release Sandostatin® (octreotide acetate) Injection has been shown to be effective and tolerated for:
- Long-term maintenance therapy in acromegalic patients who have had inadequate response to surgery and/or radiotherapy or for whom surgery and/or radiotherapy is not an option (the goal of treatment in acromegaly is to reduce GH and IGF-1 levels to normal).
- Long-term treatment of the severe diarrhea and flushing episodes associated with metastatic carcinoid tumors.
- Long-term treatment of the profuse watery diarrhea associated with VIP-secreting tumors
In patients with carcinoid syndrome and VIPomas, the effect of Sandostatin Injection and Sandostatin LAR Depot on tumor size, rate of growth and development of metastases has not been determined.
IMPORTANT SAFETY INFORMATION
Warnings and precautions: Treatment with Sandostatin LAR Depot may affect gallbladder function, sugar metabolism, thyroid and heart function, and nutritional absorption, which may require monitoring by your doctor.
Before taking Sandostatin LAR Depot: Tell your doctor if you have a history of heart disease or are taking other medications, including: cyclosporine, insulin, oral hypoglycemic agents, beta-blockers, and bromocriptine.
Common side effects: Most patients experience side effects at some time. Some common side effects you may experience include:
- Acromegaly: diarrhea, gallstones, abdominal pain, and flatulence
- Carcinoid tumors: back pain, fatigue, headache, abdominal pain, nausea, and dizziness
Other information: Patients with carcinoids tumors and VIPomas should adhere closely to their scheduled return visits for reinjection in order to minimize exacerbation of symptoms. Patients with acromegaly should adhere to their return visit schedule to help assure steady control of GH and IGF-1 levels.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
